论文部分内容阅读
我院内二科受中国人民解放军医药信息情报研究所之委托于1994年1月一1996年7月应用军事医学科学院基础医学研究所试制白介素一2（rhIL—2）94（卫药试字gnl）作治疗淋巴瘤m期科研验证并用环磷酸胺（CTX）、长春新碱（VCR）、高三尖杉酯碱（H）、强的松（P），组成COHP方案治疗
The second department of our hospital was commissioned by the People’s Liberation Army Medical Information and Information Research Institute to apply the trial of interleukin-2 (rhIL-2) 94 (Guardian test word gnl) from January 1994 to July 1996 in the Institute of Basic Medical Sciences, Academy of Military Medical Sciences. Used for the treatment of lymphoma in m phase and validated with the combination of cyclophosphamide (CTX), vincristine (VCR), homoharringtonine (H) and prednisone (P).